International Journal of Clinical Oncology and Cancer Research

Archive

Volume 10, Issue 1, March 2025

  • Research Article

    Diagnostic and Prognostic Significance of Serum Biomarkers CA 125 and CA 19-9 in Ovarian Cancer

    Monowara Begum*, Sadia Jabeen Khan, Sayada Fatema Khatun, Suraiya Khanom, Nasrin Akter, Jannatul Ferdous, Mahmud-Un-Nabi

    Issue: Volume 10, Issue 1, March 2025
    Pages: 1-6
    Received: 21 December 2024
    Accepted: 3 January 2025
    Published: 21 January 2025
    DOI: 10.11648/j.ijcocr.20251001.11
    Downloads:
    Views:
    Abstract: Background: Ovarian cancer is a significant cause of gynecological cancer-related mortality, with early diagnosis being critical for better outcomes. Serum biomarkers CA 125 and CA 19-9 are widely studied for their diagnostic and prognostic significance in ovarian cancer. Methods: This cross-sectional study analyzed 80 ovarian cancer patients from ... Show More
    Download PDF
    View Online
  • Research Article

    Impact of Preoperative Systemic Inflammation Score on Key Prognostic Risk Factors in Early Cervical Cancer

    Syfun Naher*, Naznine Akter, Riffat Ara Sharmin, Rita Roy, Fawzia Hossain, Jakanta Faika, Khandker Tafriha Rahman, Asim Kumar Saha, Mofazzal Hossen

    Issue: Volume 10, Issue 1, March 2025
    Pages: 7-13
    Received: 23 December 2024
    Accepted: 6 January 2025
    Published: 23 January 2025
    DOI: 10.11648/j.ijcocr.20251001.12
    Downloads:
    Views:
    Abstract: Background: Cervical cancer is the fourth most common malignancy in women across the world. Treatment decisions for early cervical cancer are guided by prognostic risk factors including tumor size, LVSI, depth of stromal invasion and nodal involvement. Systemic inflammation score (SIS) is a novel prognostic biomarker which is potential for differen... Show More
    Download PDF
    View Online
  • Research Article

    Comparative Study Between 17 Gy in 2 Fractions and 36 Gy in 12 Fractions Radiotherapy to Primary Site for Palliation of Symptoms in Stage IV Non-Small Cell Lung Cancer

    Saiful Alam*, Md. Golam Zel Asmaul Husna, Shahida Alam, M Nizamul Haque, Muhammad Abdullah-Al-Noman, Shuvra Debnath, Tanin Sultana, Md. Rakibul Islam Masud, Altaf Hossain, Tasneem Hossain, Tasnim Mahmud

    Issue: Volume 10, Issue 1, March 2025
    Pages: 14-26
    Received: 8 January 2025
    Accepted: 19 February 2025
    Published: 6 March 2025
    DOI: 10.11648/j.ijcocr.20251001.13
    Downloads:
    Views:
    Abstract: Background: Half of NSCLC patients present with stage IV disease where a cure is not possible. The use of a hypofractionated RT schedule has economic and logistic advantages for Radiation Oncology departments and a higher degree of patient convenience than conventional fractionation. Objective: To evaluate outcomes between 17 Gy in 2 fractions and ... Show More
    Download PDF
    View Online
  • Research Article

    Cytotoxic Agents Can Cure Cancer, but Can Also Kill Cancer Patients

    Ming Cheng Liau*, Christine Liau Craig, Linda Liau Baker

    Issue: Volume 10, Issue 1, March 2025
    Pages: 27-35
    Received: 5 February 2025
    Accepted: 17 February 2025
    Published: 7 March 2025
    DOI: 10.11648/j.ijcocr.20251001.14
    Downloads:
    Views:
    Abstract: The objective of this article is to rectify cytotoxic cancer therapies which are inadequate to cause escalating cancer mortality, and to promote cell differentiation agent (CDA) formulations as perfect cancer drugs to reduce cancer mortality. Cancer mortality is the ultimate judgment of the success of cancer therapy. Cancer mortality keeps on incre... Show More
    Download PDF
    View Online

About Us

Science Publishing Group (SciencePG) is an Open Access publisher, with more than 300 online, peer-reviewed journals covering a wide range of academic disciplines.

Learn More About SciencePG

Products

Information

Important Link

Copyright © 2012 -- 2025 Science Publishing Group – All rights reserved.